8 important items from ICRS
Click Here to Manage Email Alerts
Orthopedics Today features eight stories of importance to emerge from the International Cartilage Repair Society Annual Meeting.
Patients who experienced symptomatic relief did not complete autologous cartilage implantation
CHICAGO — Almost half of patients scheduled to undergo autologous cartilage implantation did not complete both stages of the procedure due to symptomatic relief, according to results presented here. Read more.
Study: Microfracture has lowest per-patient average charges for cartilage repair surgery
CHICAGO — A review of per-patient average charges for cartilage repair surgery showed microfracture had the lowest charges, supporting the theory that this method of repair should be considered the gold standard of chondral defect management, according to a presenter here. Read more.
Higher risk of medial end-stage OA found in patients with constitutional varus
CHICAGO — Patients with constitutional varus had a higher risk of developing medial end-stage osteoarthritis, according to a presenter here. Read more.
MACI, novel treatment clinically valid for femoroacetabular impingement
CHICAGO — For the treatment of cartilage defects resulting from femoroacetabular impingement, both matrix autologous chondrocyte implantation and autologous matrix-induced chondrogenesis presented as clinically valid treatment options, according to a presenter here. Read more.
CHICAGO — MRI appearance of autologous chondrocyte implantation showed imaging abnormalities at 65.8-month follow-up; however, autologous chondrocyte implantation was still found to produce good clinical results, according to data presented at the International Cartilage Repair Society Annual Meeting. Read more.
Several factors predict grade IV chondral defects in the hip
CHICAGO — Several factors were associated with grade IV chondral defects in patients undergoing hip arthroscopy, according to results presented at the International Cartilage Repair Society Annual Meeting. Read more.
Autologous chondrocyte implantation on biphasic scaffold improved pain and function
CHICAGO — Significant medium- to long-term improvements in pain and function were demonstrated among patients who underwent autologous chondrocyte implantation on a biphasic scaffold, according to a presenter here. Read more.
No return to OR found 90 days after meniscal allograft transplantation
CHICAGO — No return to the operating room was found at 90 days following meniscal allograft transplantation, according to a presenter at the International Cartilage Repair Society Annual Meeting. Read more.